-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Initiates Coverage On Centessa Pharmaceuticals with Buy Rating

Benzinga·01/07/2025 17:04:50
Listen to the news
TD Cowen analyst Stacy Ku initiates coverage on Centessa Pharmaceuticals (NASDAQ:CNTA) with a Buy rating.